Global Onychomycosis Drug Market Analysed & Forecast in New GlobalInfoResearch Study Available at MarketPublishers.com

11 May 2017 • by Natalie Aster

LONDON – Onychomycosis, a.k.a. tinea unguium, is an infection of toenails or fingernails caused by fungus. Today, systemic drug treatment is the key and the most effective treatment method for this infection.

The onychomycosis drug market is following an upward trend due to such factors as the rise in R&D activities, introduction of new safer and more effective drugs with advanced disease-modifying properties, increasing healthcare expenditures, surging number of onychomycosis incidence (especially in the USA and Canada), growing number of diabetics worldwide, rapidly aging population, mushrooming demand for effective treatment options for onychomycosis, among other growth drivers.

However, growth in the onychomycosis drug market is hampered by certain challenges, for instance, a range of side effects associated with onychomycosis drugs and low awareness about the infection amid mass population in developing regions such as APAC, the Middle East and Africa, and Latin America.

Region-wise, North America remains the unrivalled leader in the total onychomycosis drug market. Europe ranks the second regional market for onychomycosis drugs. In the offing, the fastest growth is expected to be observed in the APAC onychomycosis drug market.

New topical study “Global Onychomycosis (Tinea Unguium) Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022” prepared by GlobalInfoResearch provides a deep insight into the world’s onychomycosis drug market environment. The research publication covers the onychomycosis drug market scenario at the global scale and across the major geographies (North America, Europe, Asia-Pacific, South America, Middle East and Africa). It offers the market segmentation analysis on the basis of manufacturers, regions, types and applications.  

Moreover, this insightful research report delves deep into the market dynamics, examining the key growth drivers, hinders and restraints. It presents reliable information on the ongoing and emerging trends and opportunities in the global marketplace till 2022. The report also covers the existing products, market risks, sales, revenues, drug sales channels, as well as explores the competitive situation and identifies the top manufacturers, distributors, traders, and dealers. Besides, future forecasts through 2022 are also available in the report.

Other comprehensive market research reports by GlobalInfoResearch are available in this Market Publishers’ catalogue.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com